BPC-157 + TB-500 Blend

This is BPC-157 and TB-500 co-lyophilised at a 1:1 mass ratio in a single vial. The pairing is the most common combination in connective tissue literature, on the reasoning that the two act through separable mechanisms — BPC-157 through angiogenic and nitric oxide pathways, TB-500 through actin sequestration and cell migration — so a combined preparation lets a single experimental arm cover both.

Blended vials are where certificate quality is most often quietly abandoned across this industry, because one purity number for a mixture is not a meaningful figure. Our approach is three assays, not one: each component is assayed independently before blending, then the finished vial is assayed again by a gradient that resolves both peaks, and the certificate reports a purity and a measured mass ratio per component. If a blend certificate you are reading elsewhere shows a single number, it cannot tell you whether the ratio in the vial is the ratio on the label.